Skip to main content

Helicos BioSciences Sequences M13 Bacteriophage

NEW YORK, Dec. 19 (GenomeWeb News) - Helicos BioSciences said today that it has sequenced the genome of the M13 bacteriophage with its non-amplified True Single Molecule Sequencing technology.


The tSMS technology was used in conjunction with Helicos' SimplePrep genome preparation technique.


Helicos said that tSMS, which enables direct interrogation of a single molecule without amplication, offers a number of benefits, including no PCR bias, fewer errors, and no dephasing issues. The company said that the method costs around 1,000 times less than Sanger sequencing.


Sequencing of M13 was conducted on the entire genome, including homopolymeric sequences. The M13 genome is 6,400 base pairs long and encodes for 10 genes.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.